The funds will support a variety of business activities including diagnostic test development and the advance of new methods for tissue-specific exosome isolation.
The consumer genomics company will expand its suite of canine genetic tests, and has relocated its headquarters from Boston to Austin.
Qiagen opened its Chinese translational medicine venture in 2013 in partnership with BioBay, a life sciences cluster in Suzhou Industrial Park.
GeneNews has signed a binding agreement with multinational private equity firm Milost Global for up to $10 million in equity and debt financing.
The sample prep technologies firm intends to use the funding to expand its commercial channels, among other things.
The company previously said that it planned to publicly offer up to $10 million in stocks and warrants. It has not priced the offering yet.
DayTwo currently offers a personalized nutrition service that includes DNA sequencing of a customer's gut bacteria.
The company said it will use the funding to develop and commercialize its proprietary biomedical data analysis and machine learning platform.
SerImmune is developing an immune mapping technology that uses next-generation sequencing to identify how circulating antibodies pair with antigens.
The British genetics company will use the proceeds to support the roll out of its Alzheimer's disease testing service.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
In Nature this week: a Danish reference genome, and more.